Check our new article entitled “Contribution of abnormal BMI to adverse health-related quality of life outcomes after a 52-week long therapy in patients with SLE” in Rheumatology (Oxford).
You May Also Like

Precision medicine in lupus – Ioannis Parodis interviewed by Lupus Hub
Robert TonoianJuly 26, 2024